Influence of an "opt-out" test strategy and patient factors on human immunodeficiency virus screening in pregnancy

Obstetrics and Gynecology

Volumn 110, Issue 1, 2007, Pages 81-86

  Yudin, Mark H ^a   Moravac, Catherine ^a   Shah, Rajiv R ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASIAN; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; ENGLISH AS A SECOND LANGUAGE; FEMALE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; PREDICTION; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLE SIZE; SCREENING TEST; TREATMENT REFUSAL;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; DECISION MAKING; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 34347359801     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000267497.39041.06     Document Type: Article

References (18)

1. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance report to December 31, 2005. 2005. Available at: http://www.phac-aspc.gc.ca/publicat/ aids-sida/haic-vsac1205/index.html. Retrieved April 12, 2007.
2. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
3. Cooper ER, Charurat M, Mofenson L, Hanson EC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29:484-94.
4. Society of Obstetricians and Gynecologists of Canada. Clinical Practice Guidelines, Policy Statement: HIV testing in pregnancy. J Obstet Gynaecol Canada 1997;19:767-8.
5. ACOG Committee on Obstetric Practice. ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol 2004;104:1119-24.
6. Samson L, King S. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada [published erratum appears in CMAJ 1998;159:22]. CMAJ 1998;158:1449-57.
7. Stringer EM, Stringer JS, Cliver SP, Goldenberg RL, Goepfert AR. Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol 2001;98:1104-8.
8. Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. CMAJ 2003;168:679-82.
9. Centers for Disease Control and Prevention (CDC). HIV testing among pregnant women-United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep 2002;51:1013-6.
10. Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep 2001;50:63-85.
11. Breese P, Burman W, Shlay J, Guinn D. The effectiveness of a verbal opt-out system for human immunodeficiency virus screening during pregnancy. Obstet Gynecol 2004;104:134-7.
12. Ontario HIV Epidemiologic Monitoring Unit. Mandate. Available at: http://www.phs.utoronto.ca/ohemu/mandate.html. Retrieved October 20, 2006.
13. Simpson WM, Johnstone FD, Goldberg DJ, Gormley SM, Hart GJ. Antenatal HIV testing: assessment of a routine voluntary approach. BMJ 1999;318:1660-1.
14. Wang F, Larke B, Gabos S, Hanrahan A, Schopflocher D. Potential factors that may affect acceptance of routine prenatal HIV testing. Can J Public Health 2005;96:60-4.
15. Ethier KA, Fox-Tierney R, Nicholas WC, Salisbury KM, Ickovics JR. Organizational predictors of prenatal HIV counseling and testing. Am J Public Health 2000;90:1448-51.
16. Lansky A, Jones JL, Frey RL, Lindegren ML. Trends in HIV testing among pregnant women: United States, 1994-1999. Am J Public Health 2001;91:1291-3.
17. Lindsay MK, Adefris W, Peterson HB, Williams H, Johnson J, Klein L. Determinants of acceptance of routine voluntary human immunodeficiency virus testing in an inner-city prenatal population. Obstet Gynecol 1991;78:678-80.
18. Ogilvie G, Adsett S, Macdonald G. Do physicians discuss HIV testing during prenatal care? Can Fam Physician 1997;43:1376-81.